Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
Current Topics in Medicinal Chemistry
|
March 12, 2019
Small-Molecule Immuno-Oncology Therapy: Advances, Challenges and New Directions
Shulun Chen, Zilan Song, Ao Zhang
Bioorganic Chemistry
|
March 27, 2021
The ups, downs and new trends of IDO1 inhibitors
Shulun Chen, Jing Tan, Ao Zhang
ACS Applied Materials & Interfaces
|
August 30, 2017
Bipolar Electrode Array Embedded in a Polymer Light-Emitting Electrochemical Cell
Jun Gao, Shulun Chen, Faleh AlTal, et al.
European Journal of Medicinal Chemistry
|
June 25, 2019
Design, synthesis and antitumor study of a series of N-Cyclic sulfamoylaminoethyl substituted 1,2,5-oxadiazol-3-amines as new indoleamine 2, 3-dioxygenase 1 (IDO1) inhibitors
Shulun Chen, Wei Guo, Xiaohua Liu, et al.
Acta Pharmaceutica Sinica. B
|
March 5, 2025
Design, synthesis and pharmacological evaluation of 1,2,3,4-tetrahydrobenzofuro[2,3-<i>c</i>]pyridine derivatives as p21-activated kinase 4 inhibitors for treatment of pancreatic cancer
Yang Li, Yan Fang, Xiaoyu Chen, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
Current Topics in Medicinal Chemistry
|
March 12, 2019
Small-Molecule Immuno-Oncology Therapy: Advances, Challenges and New Directions
Shulun Chen, Zilan Song, Ao Zhang
Bioorganic Chemistry
|
March 27, 2021
The ups, downs and new trends of IDO1 inhibitors
Shulun Chen, Jing Tan, Ao Zhang
ACS Applied Materials & Interfaces
|
August 30, 2017
Bipolar Electrode Array Embedded in a Polymer Light-Emitting Electrochemical Cell
Jun Gao, Shulun Chen, Faleh AlTal, et al.
European Journal of Medicinal Chemistry
|
June 25, 2019
Design, synthesis and antitumor study of a series of N-Cyclic sulfamoylaminoethyl substituted 1,2,5-oxadiazol-3-amines as new indoleamine 2, 3-dioxygenase 1 (IDO1) inhibitors
Shulun Chen, Wei Guo, Xiaohua Liu, et al.
Acta Pharmaceutica Sinica. B
|
March 5, 2025
Design, synthesis and pharmacological evaluation of 1,2,3,4-tetrahydrobenzofuro[2,3-<i>c</i>]pyridine derivatives as p21-activated kinase 4 inhibitors for treatment of pancreatic cancer
Yang Li, Yan Fang, Xiaoyu Chen, et al.
Page
of 1